COX-2: A target for colon cancer prevention

被引：256
|
作者：
Marnett, LJ
DuBois, RN
机构：
[1] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res, Ctr Mol Toxicol,Dept Biochem, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res, Ctr Mol Toxicol,Dept Chem, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res, Ctr Mol Toxicol,Dept Med, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res, Ctr Mol Toxicol,Dept Cell Biol, Nashville, TN 37232 USA
[5] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Comprehens Canc Ctr, Nashville, TN 37232 USA
来源：
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY | 2002年 / 42卷
关键词：
cyclooxygenase; prostaglandins; NSAIDs; cancer; prevention;
D O I：
10.1146/annurev.pharmtox.42.082301.164620
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Disease prevention is one area that both public and governmental agencies strongly support owing to its potential for an improved lifestyle and a reduction in health care costs. In this review, we focus on the clinical development of one target for cancer prevention, the COX-2 enzyme. This provides an excellent example of how basic research in biochemistry and pharmacology can lead to translational studies and eventually to approval of a drug by the FDA for use as a chemopreventive agent in humans. It is hoped that, as the genome sequence: is understood more clearly, other targets will emerge that will provide even more effective drugs for future cancer prevention.
引用
收藏
页码：55 / +
页数：26
相关论文
共 50 条
  • [1] Mechanisms of colon cancer prevention with and beyond COX-2 inhibition
    Rodríguez-Moranta, F
    Castells, A
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (05) : 505 - 516
  • [2] COX-2 as a target for cancer chemotherapy
    Ghosh, Nilanjan
    Chaki, Rituparna
    Mandal, Vivekananda
    Mandal, Subhash C.
    PHARMACOLOGICAL REPORTS, 2010, 62 (02) : 233 - 244
  • [3] COX-2 inhibition and prevention of cancer
    Giercksky, KE
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2001, 15 (05) : 821 - 833
  • [4] COX-2 as a target for cancer chemotherapy
    Nilanjan Ghosh
    Rituparna Chaki
    Vivekananda Mandal
    Subhash C. Mandal
    Pharmacological Reports, 2010, 62 : 233 - 244
  • [5] COX-2 and colorectal cancer
    Ferrández, A
    Prescott, S
    Burt, RW
    CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (27) : 2229 - 2251
  • [6] Is COX-2 inhibition a panacea for cancer prevention?
    Vainio, H
    INTERNATIONAL JOURNAL OF CANCER, 2001, 94 (05) : 613 - 614
  • [7] COX-2 and colon cancer: Potential targets for chemoprevention
    Fournier, DB
    Gordon, GB
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2000, : 97 - 102
  • [8] COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib
    Grösch, S
    Tegeder, I
    Niederberger, E
    Bräutigam, L
    Geisslinger, G
    FASEB JOURNAL, 2001, 15 (12) : 2742 - +
  • [9] Cox-2 is needed but not sufficient for apoptosis induced by Cox-2 selective inhibitors in colon cancer cells
    B. Agarwal
    P. Swaroop
    P. Protiva
    S. V. Raj
    H. Shirin
    P. R. Holt
    Apoptosis, 2003, 8 : 649 - 654
  • [10] Cox-2 is needed but not sufficient for apoptosis induced by Cox-2 selective inhibitors in colon cancer cells
    Agarwal, B
    Swaroop, P
    Protiva, P
    Raj, SV
    Shirin, H
    Holt, PR
    APOPTOSIS, 2003, 8 (06) : 649 - 654
12345